AstraZeneca Drug Cocktail Succeeds in Late-Stage Study To Treat COVID-19
The British drugmaker also said that the experimental COVID-19 drug has helped in reducing the risk of death and severe disease. The drug, which is a mix of two antibodies, is both a preventative medicine and treatment for coronavirus.
AstraZeneca on Monday said that its experimental drug cocktail has succeeded in late-stage Study to treat COVID-19. The British drugmaker also said that the experimental COVID-19 drug has helped in reducing the risk of death and severe disease. The drug, which is a mix of two antibodies, is both a preventative medicine and treatment for coronavirus.
AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19 https://t.co/keW3HFJSLX pic.twitter.com/rsLLBdkPBk
— Reuters (@Reuters) October 11, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Oct 11, 2021 12:50 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
